Bicycle Therapeutics plc (BCYC) Misses Q3 EPS by 7c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q3 EPS of ($0.96), $0.07 worse than the analyst estimate of ($0.89). Revenue for the quarter came in at $3.04 million versus the consensus estimate of $5.58 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Ulta Beauty (ULTA) Tops Q2 EPS by 38c, Offers Outlook
• Hafnia Limited (HAFN) Tops Q2 EPS by 1c